Meeting of the Advisory Committee on Infant and Maternal Mortality, 47155-47156 [2024-11968]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 106 / Friday, May 31, 2024 / Notices
Furthermore, the normal operations of
a healthcare provider are disrupted by
emergencies or disasters occasionally.
When this occurs, State Survey
Agencies (SA) deliver a provider/
beneficiary tracking report regarding the
current status of all affected healthcare
providers and their beneficiaries. We are
revising this information collection
streamlined automated process to
update for clarity during emergencies.
To quickly identify patient risks/needs,
CMS added fields to assess sufficient
staffing, equipment and supplies as well
as added an assessment of a cyber
security attack on the care and services
provided to patients (if applicable).
Moreover, to decrease the time/effort of
stakeholders (State Survey Agencies
(SAs)/Providers) submitting this data
during emergencies, CMS also added a
feature to autofill multiple fields when
the stakeholder documents a valid CMS
Certification Number (CCN). This
streamlined automated process will
consist of a public facing web form as
well as a process for SAs/Providers to
submit data using extracts (CSV or
Excel) on emergent events impacting
Health Care Facilities via automated
mail handler system. Both processes
(public facing web form and extracts via
an automated mail handler system) are
known as the Health Care Facility (HCF)
Operational Status. Finally, Acute
Hospital Care at Home waiver is granted
at the individual hospital/CMS
Certification Number (CCN) level and
waives § 482.23(b) and (b)(1) of the
Hospital Conditions of Participation
(CoPs) which require nursing services to
be provided on premises 24 hours a day,
7 days a week and the immediate
availability of a registered nurse for care
of any patient (This waiver allows
hospitals to utilize models of at-home
hospital care). This Acute Hospital Care
at Home web form was revised to add
questions for the respondents to meet
requirements for all hospitals for (1) the
Patient Rights CoP at 42 CFR 482.13, (2)
the Consolidated Appropriations Act of
2023 and (3) for emergency response.
Form Number: CMS–10752 (OMB
control number: 0938–1384); Frequency:
Occasionally; Affected Public: Private
Sector: Business or other for-profits and
Not-for-profit institutions and State,
Local or Tribal Governments; Number of
Respondents: 1,020; Total Annual
Responses: 11,916; Total Annual Hours:
11,916. (For policy questions regarding
this collection, contact Adriane
Saunders at 404–562–7484.)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
William N. Parham III,
Director, Division of Information Collections
and Regulatory Impacts, Office of Strategic
Operations and Regulatory Affairs.
Health Resources and Services
Administration
[FR Doc. 2024–11978 Filed 5–30–24; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Advisory Commission on Childhood
Vaccines Meeting; Correction
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
AGENCY:
ACTION:
Notice; correction.
HRSA published a document
in the Federal Register on February 26,
2024, setting forth the meeting schedule
for the 2024 Advisory Commission on
Childhood Vaccines (ACCV). The ACCV
held two of its 2024 meetings on March
7, 2024, and March 8, 2024. The
remaining two 2024 ACCV meetings
originally scheduled for September 5,
2024, and September 6, 2024, are
rescheduled for July 11, 2024, 12:30
p.m. ET—4:30 p.m. ET, and July 12,
2024, 12:00 p.m. ET—4:15 p.m. ET.
SUMMARY:
Pita
Gomez, Principal Staff Liaison, Division
of Injury Compensation Programs,
HRSA, 5600 Fishers Lane, 8W–25A,
Rockville, Maryland 20857; 800–338–
2382; or ACCV@hrsa.gov.
FOR FURTHER INFORMATION CONTACT:
SUPPLEMENTARY INFORMATION:
Correction
In the Federal Register of February
26, 2024, FR Doc. 2024–03824, page
14080, column 1, correct the Dates
caption to read ‘‘The ACCV meetings
will be held on:
• March 7, 2024, 1 p.m. ET—4 p.m. ET;
• March 8, 2024, 1 p.m. ET—4 p.m. ET;
• July 11, 2024, 12:30 p.m. ET—4:30
p.m. ET;
• July 12, 2024, 12:00 p.m. ET—4:15
p.m. ET.’’
Maria G. Button,
Director, Executive Secretariat.
BILLING CODE 4165–15–P
17:22 May 30, 2024
Jkt 262001
PO 00000
Frm 00035
Fmt 4703
Meeting of the Advisory Committee on
Infant and Maternal Mortality
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
[FR Doc. 2024–11962 Filed 5–30–24; 8:45 am]
VerDate Sep<11>2014
47155
Sfmt 4703
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Advisory
Committee on Infant and Maternal
Mortality (ACIMM or Committee) has
scheduled a public meeting. Information
about ACIMM and the agenda for this
meeting can be found on the ACIMM
website at https://www.hrsa.gov/
advisory-committees/infant-mortality/
index.html.
SUMMARY:
June 26, 2024, from 9:30 a.m. to
5 p.m. eastern time and June 27, 2024,
from 9:30 a.m. to 4 p.m. eastern time.
ADDRESSES: This meeting will be held in
person at HRSA Headquarters, 5600
Fishers Lane, Conference Room 5W07,
Rockville, Maryland 20857, and
virtually via webinar. The webinar link
and log-in information will be available
at the ACIMM website before the
meeting: https://www.hrsa.gov/advisorycommittees/infant-mortality/.
FOR FURTHER INFORMATION CONTACT:
Vanessa Lee, MPH, Designated Federal
Official, Maternal and Child Health
Bureau, HRSA, 5600 Fishers Lane,
Rockville, Maryland 20857; 301–443–
0543; or SACIM@hrsa.gov.
SUPPLEMENTARY INFORMATION: ACIMM is
authorized by section 222 of the Public
Health Service Act (42 U.S.C. 217a), as
amended. The Committee is governed
by provisions of the Federal Advisory
Committee Act (5 U.S.C. chapter 10), as
amended.
ACIMM advises the Secretary of
Health and Human Services on
department activities, partnerships,
policies, and programs directed at
reducing infant mortality, maternal
mortality and severe maternal
morbidity, and improving the health
status of infants and women before,
during, and after pregnancy. The
Committee provides advice on how to
coordinate Federal, State, local, Tribal,
and territorial governmental efforts
designed to improve infant mortality,
related adverse birth outcomes,
maternal health, as well as influence
similar efforts in the private and
voluntary sectors. The Committee
provides guidance and
DATES:
E:\FR\FM\31MYN1.SGM
31MYN1
47156
Federal Register / Vol. 89, No. 106 / Friday, May 31, 2024 / Notices
recommendations on the policies,
programs, and resources required to
address the disparities and inequities in
infant mortality, related adverse birth
outcomes and maternal health
outcomes, including maternal mortality
and severe maternal morbidity. With its
focus on underlying causes of the
disparities and inequities seen in birth
outcomes for women and infants, the
Committee advises the Secretary of
Health and Human Services on the
health, social, economic, and
environmental factors contributing to
the inequities and proposes structural,
policy, and/or systems level changes.
The agenda for the June 26–27, 2024,
meeting is being finalized and may
include the following topics: Federal
updates, including on the Healthy Start
program; maternal and infant mental
health; presentations and Committee
discussions on the workgroup topics of
rural health care access, social drivers of
health, and women’s health before/
between pregnancies; and discussion of
possible recommendations to achieve
optimal maternal health and overall
birth outcomes for underserved
populations, including Black/AfricanAmerican families. Agenda items are
subject to change as priorities dictate.
Refer to the ACIMM website listed
above for any updated information
concerning the meeting.
khammond on DSKJM1Z7X2PROD with NOTICES
Members of the public will have the
opportunity to provide written or oral
comments. Public participants may
submit written statements in advance of
the scheduled meeting by emailing
SACIM@hrsa.gov. Oral comments will
be honored in the order they are
requested and may be limited as time
allows. Requests to submit a written
statement or make oral comments to
ACIMM should be sent to Vanessa Lee,
Designated Federal Official, using the
email address above at least 3 business
days prior to the meeting.
Individuals who plan to attend and
need special assistance or another
reasonable accommodation should
notify Vanessa Lee at the contact
information listed above at least 10
business days prior to the meeting.
Since this meeting occurs in a Federal
Government building, attendees joining
in person must go through a security
check to enter the building. Non-U.S.
Citizen attendees must notify HRSA of
their planned attendance at least 20
business days prior to the meeting to
facilitate their entry into the building.
All attendees are required to present
VerDate Sep<11>2014
17:22 May 30, 2024
Jkt 262001
government-issued identification prior
to entry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Maria G. Button,
Director, Executive Secretariat.
National Institutes of Health
[FR Doc. 2024–11968 Filed 5–30–24; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; URGenT: Translational
Efforts to Advance Gene-based Therapies for
Ultra-Rare Neurological and Neuromuscular
Disorders.
Date: June 27, 2024.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Mirela Milescu, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH/DHHS, NSC, 6001 Executive
Boulevard, Rockville, MD 20852, 301–496–
5720, mirela.milescu@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
Dated: May 24, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–11970 Filed 5–30–24; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; NSD–A/B Member Conflict
SEP.
Date: June 24, 2024.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Surojeet Sengupta, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH/DHHS, NSC, 6001 Executive
Boulevard, Room 5134 Rockville, MD 20852,
301–496–9223, surojeet.sengupta@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Validation of Biomarkers.
Date: June 25, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Surojeet Sengupta, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH/DHHS, NSC, 6001 Executive
Boulevard, Room 5134, Rockville, MD 20852,
301–496–9223, surojeet.sengupta@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
E:\FR\FM\31MYN1.SGM
31MYN1
]]>Agencies
[Federal Register Volume 89, Number 106 (Friday, May 31, 2024)]
[Notices]
[Pages 47155-47156]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-11968]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the Advisory Committee on Infant and Maternal
Mortality
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Advisory Committee on Infant and Maternal
Mortality (ACIMM or Committee) has scheduled a public meeting.
Information about ACIMM and the agenda for this meeting can be found on
the ACIMM website at https://www.hrsa.gov/advisory-committees/infant-mortality/.
DATES: June 26, 2024, from 9:30 a.m. to 5 p.m. eastern time and June
27, 2024, from 9:30 a.m. to 4 p.m. eastern time.
ADDRESSES: This meeting will be held in person at HRSA Headquarters,
5600 Fishers Lane, Conference Room 5W07, Rockville, Maryland 20857, and
virtually via webinar. The webinar link and log-in information will be
available at the ACIMM website before the meeting: https://www.hrsa.gov/advisory-committees/infant-mortality/.
FOR FURTHER INFORMATION CONTACT: Vanessa Lee, MPH, Designated Federal
Official, Maternal and Child Health Bureau, HRSA, 5600 Fishers Lane,
Rockville, Maryland 20857; 301-443-0543; or [email protected].
SUPPLEMENTARY INFORMATION: ACIMM is authorized by section 222 of the
Public Health Service Act (42 U.S.C. 217a), as amended. The Committee
is governed by provisions of the Federal Advisory Committee Act (5
U.S.C. chapter 10), as amended.
ACIMM advises the Secretary of Health and Human Services on
department activities, partnerships, policies, and programs directed at
reducing infant mortality, maternal mortality and severe maternal
morbidity, and improving the health status of infants and women before,
during, and after pregnancy. The Committee provides advice on how to
coordinate Federal, State, local, Tribal, and territorial governmental
efforts designed to improve infant mortality, related adverse birth
outcomes, maternal health, as well as influence similar efforts in the
private and voluntary sectors. The Committee provides guidance and
[[Page 47156]]
recommendations on the policies, programs, and resources required to
address the disparities and inequities in infant mortality, related
adverse birth outcomes and maternal health outcomes, including maternal
mortality and severe maternal morbidity. With its focus on underlying
causes of the disparities and inequities seen in birth outcomes for
women and infants, the Committee advises the Secretary of Health and
Human Services on the health, social, economic, and environmental
factors contributing to the inequities and proposes structural, policy,
and/or systems level changes.
The agenda for the June 26-27, 2024, meeting is being finalized and
may include the following topics: Federal updates, including on the
Healthy Start program; maternal and infant mental health; presentations
and Committee discussions on the workgroup topics of rural health care
access, social drivers of health, and women's health before/between
pregnancies; and discussion of possible recommendations to achieve
optimal maternal health and overall birth outcomes for underserved
populations, including Black/African-American families. Agenda items
are subject to change as priorities dictate. Refer to the ACIMM website
listed above for any updated information concerning the meeting.
Members of the public will have the opportunity to provide written
or oral comments. Public participants may submit written statements in
advance of the scheduled meeting by emailing [email protected]. Oral
comments will be honored in the order they are requested and may be
limited as time allows. Requests to submit a written statement or make
oral comments to ACIMM should be sent to Vanessa Lee, Designated
Federal Official, using the email address above at least 3 business
days prior to the meeting.
Individuals who plan to attend and need special assistance or
another reasonable accommodation should notify Vanessa Lee at the
contact information listed above at least 10 business days prior to the
meeting. Since this meeting occurs in a Federal Government building,
attendees joining in person must go through a security check to enter
the building. Non-U.S. Citizen attendees must notify HRSA of their
planned attendance at least 20 business days prior to the meeting to
facilitate their entry into the building. All attendees are required to
present government-issued identification prior to entry.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024-11968 Filed 5-30-24; 8:45 am]
BILLING CODE 4165-15-P
